Picture of Biovica International AB logo

BIOVIC B — Biovica International AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Biovica Q4 Operating Loss Widens To SEK 37.2 Mln

June 21 (Reuters) - Biovica International AB
 BIOVICb.ST :
    * Q4 NET SALES SEK 0.6 MILLION VERSUS SEK 1.1 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 37.2 MILLION VERSUS LOSS SEK 19.1
MILLION
YEAR AGO
    * WE ARE FACING A DIFFICULT ENVIRONMENT IN FINANCIAL MARKET
WHERE
RISK APPETITE IS LOW
    * RIGHTS ISSUE EXECUTED DURING FALL 2022 REFLECTS THIS AND
MEANS
THAT WE MUST BE COST CONSCIOUS AND CAREFUL WITH COMMERCIAL AND
CLINICAL INVESTMENTS
    * OUR OUTLOOK FOR FUTURE IS POSITIVE

Source text for Eikon:  ID:nMFN6KSCHJ 
Further company coverage:  BIOVICb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biovica International AB

See all news